erythromycin has been researched along with Adverse Drug Event in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 12 (44.44) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB | 1 |
| Berkley, JA; Williams, PCM | 1 |
| Alffenaar, JW; Buchard, A; Dalbøge, CS; Dalhoff, K; Duno, M; Høiby, N; Jensen, AG; Johansen, HK; Jürgens, G; Nielsen, XC; Pressler, T; Uges, DR | 1 |
| Gannon, M; Underhill, M; Wellik, KE | 1 |
| Islam, S; Kahn, G; Moshiree, B; Talley, NJ; Waseem, S | 1 |
| Chen, PC; Lee, CH; Wang, JD | 1 |
| Deng, S; Huang, J; Lu, S; Qiu, Z; Sui, Q; Wang, B; Yu, G; Zhao, W | 1 |
| Boutouyrie-Dumont, B | 1 |
| Metlay, JP | 1 |
| Preskorn, SH | 1 |
| Chen, JM; Huang, LM; Lee, CY; Lee, PI; Wu, MH | 1 |
| Ciummo, PE; Katz, NL | 1 |
| Pillans, PI | 1 |
| Gómez-López, T; Martínez-Quintas, MJ; Sanz, E | 1 |
| Blitzer, BL; King, PD | 1 |
| Fireman, BH; Friedman, GD; Selby, JV | 1 |
| Lauterburg, BH | 1 |
| Capron, F; Frottier, J; Verliac, F | 1 |
| Westerholm, B | 1 |
| Fossati, C | 1 |
5 review(s) available for erythromycin and Adverse Drug Event
| Article | Year |
|---|---|
Guidelines for the management of paediatric cholera infection: a systematic review of the evidence.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Cholera; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Guidelines as Topic; Humans; Infant; Infant, Newborn; Treatment Outcome; Vibrio cholerae; World Health Organization | 2018 |
Clinical inquiries. Which oral antibiotics are best for acne?
Topics: Acne Vulgaris; Administration, Oral; Anti-Bacterial Agents; Azithromycin; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Evidence-Based Medicine; Humans; Minocycline | 2011 |
Drug-induced cholestasis: pathogenesis and clinical features.
Topics: Androgens; Antidepressive Agents, Tricyclic; Bile; Bile Ducts; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Estrogens; Humans; Phenothiazines | 1990 |
[Drug damage to the liver: role of reactive metabolites and pharmacokinetics].
Topics: Acetaminophen; Amiodarone; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Glutathione; Halothane; Humans; Isoniazid; Liver; Perhexiline; Valproic Acid | 1985 |
[Liver damage due to drugs. I].
Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline | 1974 |
1 trial(s) available for erythromycin and Adverse Drug Event
| Article | Year |
|---|---|
An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Mycoplasma Infections; Pneumonia; Treatment Outcome | 2008 |
21 other study(ies) available for erythromycin and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides | 2020 |
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Biotransformation; Breath Tests; Chromatography, Liquid; Clarithromycin; Cystic Fibrosis; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Genetic Association Studies; Humans; Male; Polymorphism, Single Nucleotide; Prospective Studies; Risk Assessment; Tandem Mass Spectrometry; Treatment Failure | 2014 |
Spectrum of gastroparesis in children.
Topics: Abdominal Pain; Adolescent; Child; Child, Preschool; Diabetes Complications; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Follow-Up Studies; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Agents; Gastroparesis; Humans; Infant; Male; Nausea; Postoperative Complications; Prevalence; Prognosis; Vomiting; Weight Loss; Young Adult | 2012 |
Case-crossover design: an alternative strategy for detecting drug-induced liver injury.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chemical and Drug Induced Liver Injury; Comorbidity; Cross-Over Studies; Databases as Topic; Diclofenac; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Hospitalization; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Odds Ratio; Pregnancy; Research Design; Rifampin; Risk Assessment; Taiwan; Time Factors; Young Adult | 2012 |
Identification of priority pharmaceuticals in the water environment of China.
Topics: Anti-Bacterial Agents; Cephalexin; China; Diclofenac; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Ecosystem; Environmental Monitoring; Erythromycin; Humans; Ibuprofen; Ketoconazole; Pharmaceutical Preparations; Rivers; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2012 |
An aide memoire for model-based drug development--a new key for the interpretation of the erythromycin breath test--therapeutic index as a biomarker for smart drug development.
Topics: Animals; Anti-Bacterial Agents; Biomarkers, Pharmacological; Drug Approval; Drug Discovery; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Humans; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Orphan Drug Production; Pharmaceutical Preparations; Research Design | 2013 |
Tensions in antibiotic prescribing.
Topics: Anti-Bacterial Agents; Attitude of Health Personnel; Drug Resistance, Microbial; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Health Policy; Humans; Infection Control Practitioners; Ofloxacin; Physicians, Family; Practice Patterns, Physicians'; Public Health; United States | 2002 |
Drug-drug interactions: proof of relevance (part I).
Topics: Anti-Bacterial Agents; Antifungal Agents; Antipsychotic Agents; Cyclophilins; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Humans; Long QT Syndrome; Mental Disorders; Metronidazole | 2005 |
Interactions and drug-metabolizing enzymes.
Topics: Adolescent; Adult; Anti-Allergic Agents; Antidepressive Agents, Second-Generation; Antifungal Agents; Binding Sites; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Erythromycin; Female; Fluoxetine; Humans; Isoenzymes; Ketoconazole; Liver; Male; Middle Aged; Pharmaceutical Preparations; Terfenadine; Theophylline; Torsades de Pointes | 1995 |
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
Perception of teratogenic risk of common medicines.
Topics: Abnormalities, Drug-Induced; Chi-Square Distribution; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Health Knowledge, Attitudes, Practice; Humans; Physicians; Pregnancy; Risk Factors; Students, Medical; Teratogens; Warfarin | 2001 |
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.
Topics: Anti-Bacterial Agents; Atropa belladonna; Carcinogens; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Esophageal Neoplasms; Folic Acid; Follow-Up Studies; Gastrointestinal Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neomycin; Neoplasms; Phenylbutazone; Piperidones; Plants, Medicinal; Plants, Toxic; Polymyxin B; Propantheline; Secobarbital; Sulfathiazoles; Vitamins | 1989 |
[Unusual pseudo-infectious aspects of drug intolerance].
Topics: Ampicillin; Child, Preschool; Chloramphenicol; Colistin; Diagnosis, Differential; Drug Eruptions; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Electroencephalography; Erythromycin; Female; Fever; Humans; Hydrocortisone; Infections; Kanamycin; Kidney Diseases; Male; Middle Aged; Penicillins; Pericarditis; Pertussis Vaccine; Pleural Diseases; Recurrence; Salicylates; Tetracycline; Tonsillectomy | 1973 |
Adverse reactions from chemotherapeutic agents as seen in a national monitoring centre.
Topics: Chemical and Drug Induced Liver Injury; Chloramphenicol; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Hematuria; Humans; Nalidixic Acid; Neurologic Manifestations; Nitrofurantoin; Penicillins; Skin Manifestations; Sulfonamides; Sweden; Tetracycline | 1974 |